Loma Linda University

Enrollment Information
Call us at: 909-558-1000

Faculty Directory
David Bland, MBBS
Executive Vice Chair, Medicine
School of Medicine
Associate Professor, Medicine
School of Medicine
Research & Grantsmanship    Funded Research Project (CI)
  • A phase 2 study to evaluate dose and duration of treatment of drotrecogin alfa (activated) using serial measurements of protein C in patients with severe sepsis and multiple organ dysfunction ( 1/2007 - 1/2008 )
  • A phase 3, multicenter, randomized, placebo controlled, double blind, three arm study to evaluate the safety and efficacy of tifacogin (Recombinant tissue factor pathway inhibitor) administration in subjects with severe community acquired pneumonia ( 1/2006 - 1/2007 )